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Staphylococcus aureus Skin and Soft Tissue Infections at a Tertiary Hospital in
Botswana
Abstract
Objectives
Objectives. To study the epidemiology of Staphylococcus aureus skin and soft-tissue infections (SSTIs) in
hospitalised children and adults in Gaborone, Botswana, and to describe the changes in antimicrobial
susceptibilities of S. aureus isolates over time.
Methods
Methods. A retrospective cohort study evaluated SSTI isolates from January 2000 to December 2007 at
Princess Marina Hospital (PMH), a large tertiary referral centre in Gaborone. Eligible subjects were those
hospitalised at PMH during the study period who had a skin or soft-tissue culture yielding a bacterial or
fungal pathogen. The primary outcome measure was a skin or soft-tissue culture yielding S. aureus.
Secondary outcomes were the organism’s antimicrobial susceptibilities.
Results
Results. S. aureus was detected in 857 (35.8%) of single-organism SSTI cultures, and 194 (22.6%) of
these isolates were methicillin resistant (MRSA). The proportion of MRSA isolates increased over time
(linear test of trend: p=0.03 from 2000 to 2003), and MRSA isolates were more likely than methicillinsusceptible isolates to be resistant to commonly used antimicrobials recommended by the national SSTI
treatment guideline.
Conclusions
Conclusions. We report a high and increasing proportion of MRSA SSTIs in Gaborone. This high rate of
MRSA resistance to currently recommended empiric antibiotics for SSTIs dictates the need for revising
national guidelines and ongoing prospective surveillance of SSTIs in this setting.
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Staphylococcus aureus skin and soft-tissue infections
at a tertiary hospital in Botswana
Hong Truong, Samir S Shah, Jonathan Ludmir, Ephraim O Tawanana, Margaret Bafana,
Sarah M Wood, Howard Moffat, Andrew P Steenhoff

Objectives. To study the epidemiology of Staphylococcus aureus
skin and soft-tissue infections (SSTIs) in hospitalised children
and adults in Gaborone, Botswana, and to describe the changes in
antimicrobial susceptibilities of S. aureus isolates over time.
Methods. A retrospective cohort study evaluated SSTI isolates
from January 2000 to December 2007 at Princess Marina Hospital
(PMH), a large tertiary referral centre in Gaborone.
Eligible subjects were those hospitalised at PMH during the
study period who had a skin or soft-tissue culture yielding a
bacterial or fungal pathogen. The primary outcome measure was a
skin or soft-tissue culture yielding S. aureus. Secondary outcomes
were the organism’s antimicrobial susceptibilities.
Results. S. aureus was detected in 857 (35.8%) of single-organism
SSTI cultures, and 194 (22.6%) of these isolates were methicillin

Over the past decades, methicillin-resistant Staphylococcus aureus
(MRSA) has become a key pathogen in skin and soft-tissue infections
(SSTIs). The emergence of MRSA in 1961 occurred predominantly
in patients exposed to health care facilities;1,2 community-acquired
MRSA (CA-MRSA) isolates were identified in the 1990s.3,4 From
1993 to 2005, the impact of CA-MRSA nearly tripled emergency
department SSTI visits in the USA.4 However, there are limited
data on the incidence and characteristics of SSTIs in sub-Saharan
Africa, and knowledge of pathogen-specific attributable morbidity
is lacking.
HIV-infected patients are at markedly increased risk for CA-MRSA
SSTI. In Chicago the incidence of CA-MRSA SSTIs was 6-fold higher
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resistant (MRSA). The proportion of MRSA isolates increased over
time (linear test of trend: p=0.03 from 2000 to 2003), and MRSA
isolates were more likely than methicillin-susceptible isolates to be
resistant to commonly used antimicrobials recommended by the
national SSTI treatment guideline.
Conclusions. We report a high and increasing proportion of
MRSA SSTIs in Gaborone. This high rate of MRSA resistance to
currently recommended empiric antibiotics for SSTIs dictates the
need for revising national guidelines and ongoing prospective
surveillance of SSTIs in this setting.

S Afr Med J 2011;101:413-416.

among HIV-infected patients than among HIV-negative patients.5
Given the region’s high HIV seroprevalence rate, the impact of
MRSA may be particularly pronounced in sub-Saharan Africa.6 A
multinational surveillance project in eight African hospitals and
Malta found that 14.8% of clinically significant S. aureus strains
isolated from patients were resistant to methicillin.7 The prevalence
of MRSA isolates was even higher in sub-Saharan countries, ranging
from 16.8% in CÔte d’Ivoire to 29.6% in Nigeria.7 The prevalence
of HIV in Botswana’s general population is estimated to be 17%
and reaches nearly 35% among individuals aged 15 - 49 years, the
highest infection rate after Swaziland.8 An S. aureus colonisation
rate of 57.5% has been reported among food handlers in Gaborone,
and 11.2% of bacteraemias in this setting are caused by MRSA, with
neither study stratifying results by HIV status.9,10 Owing to the high
prevalence of HIV in Botswana and the emergence of MRSA in blood
isolates, we hypothesise that MRSA plays a significant role in SSTIs
in this setting. However, the actual incidence and characteristics of
SSTIs in this population remain unknown.
Knowledge of regional antimicrobial susceptibility patterns of
SSTI pathogens influences treatment decisions and has broad public
health implications. However, no data describing the antimicrobial
susceptibility patterns of bacteria causing SSTIs in Botswana are
available. In 2007 the Botswana Ministry of Health published
national treatment guidelines for SSTIs, recommending doxycycline
or penicillin for treatment of skin breaks with clinical signs of
bacterial infections in adults, and co-trimoxazole, erythromycin or
penicillin in children.11 These treatment guidelines and the lack of
epidemiological and antimicrobial susceptibility data on SSTIs set
the stage for this study. The primary objective was to determine
the epidemiology of S. aureus SSTIs in hospitalised children and
adults in Botswana’s capital city of Gaborone over an 8-year period.
The secondary objective was to describe temporal changes in
antimicrobial susceptibilities of S. aureus isolates over this period.

Methods
Corresponding author: J Ludmir (ludmir@mail.med.upenn.edu)

This retrospective cohort study evaluated SSTI isolates from January
2000 to December 2007 at Princess Marina Hospital (PMH) in

June 2011, Vol. 101, No. 6 SAMJ

413

ORIGINAL ARTICLES
Gaborone, Botswana. PMH is the largest tertiary care referral centre
in Botswana, with 530 beds and 20 000 - 30 000 admissions annually.
PMH provides virtually free health care to citizens of Botswana and
charges a subsidised fee to non-citizens. Since January 2002, Botswana
as a whole, and PMH in particular, have provided free highly active
antiretroviral therapy (HAART) to citizens who are HIV positive and
who meet specified clinical criteria.8 All patients hospitalised at PMH
during the study period who had a skin or soft-tissue culture yielding
a bacterial or fungal pathogen were included.
SSTI was defined as a culture of non-blood, non-stool or noncerebrospinal fluid specimens that yielded a single bacterial or fungal
pathogen. Most specimens were collected from pus, wound sites, eye,
ear, throat, vaginal swabs, pleural fluid, pericardial fluid, joint fluid
or brain abscesses. Polymicrobial skin and soft-tissue cultures were
considered contaminants and were not included. Multiple cultures
from an individual patient within 7 days of the original culture were
considered part of the same episode of SSTI and therefore excluded.
Clinical wards at PMH were categorised by three parameters: the
clinical nature of the ward (medical, surgical, intensive care unit,
accident and emergency, orthopaedic, oncology, ophthalmology,
radiology); gender (male v. female medical or orthopaedic wards);
and age of patients (neonatal, paediatric or adult).
Skin and soft-tissue cultures were subjected to microscopy, culture
and sensitivity testing. Antimicrobial susceptibility patterns of isolates
were determined by disc-diffusion methods according to Clinical
Laboratory Standards Institute guidelines.12 Antimicrobial agents
used were amikacin, ampicillin, amoxicillin-clavulanate, cefotaxime,
ceftazidime, cephradine, chloramphenicol, ciprofloxacin, clindamycin,
erythromycin, gentamicin, methicillin, penicillin G, piperacillin,
tetracycline, trimethoprim, trimethoprim-sulfamethoxazole (TMPSMX) and vancomycin. The D test for inducible clindamycin
resistance was not available. Organisms that were resistant to all of the
following were classified as multidrug-resistant organisms: ampicillin,
amoxicillin-clavulanate, cefotaxime, gentamicin, tetracycline,
trimethoprim and TMP-SMX. The proportion of resistance among
S. aureus isolates was calculated by dividing the number of resistant
isolates by the total number of isolates.
Electronic and manual records of the Botswana National Health
Laboratory were reviewed to identify skin and soft-tissue samples
that met the study criteria. Demographic data were abstracted
from the records, including anatomical site of sample, age, gender,
and the hospital ward at the time of specimen collection. Results
of antimicrobial susceptibility testing were recorded. Owing to
laboratory personnel changes, transition from manual to electronic
medical records and periodic shortages of antibiotics, there were
missing laboratory records in 39 of the 96 months (41%) of the study
period – May 2000 - July 2001, December 2002 - June 2003, April
2004 - February 2005, June 2005 - September 2005, and November
2005 - December 2005.
Data were analysed using STATA version 11.0 (Stata Corp., College
Station, TX). Continuous variables such as age were described using
mean, median, and range or interquartile range (IQR) values and
compared using the Wilcoxon rank-sum test. Categorical variables
were described using counts and percentages and compared using the
chi-square test. We used univariable logistic regression to determine
the association of individual covariates with MRSA infection and a
linear test of trend to identify changes in MRSA prevalence over time.

Results

During the study period, 2 979 (31.6%) of 9 428 cultures from SSTIs
were positive. A single organism was isolated from 2 404 (80.7%) of
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the positive cultures. S. aureus was detected in 857 (35.8%) of the
single-organism cultures.
Table I describes the demographic characteristics of patients with
S. aureus infections. MRSA accounted for 194 (22.6%) of S. aureus
isolates. Of patients with an MRSA SSTI, 55.1% were male. Patients
13 - 49 years of age accounted for almost two-thirds of cases (Table
I). The most common sites of S. aureus infection or colonisation were
vaginal swabs (N=53), wounds (N=42) and eyes (N=36). However,
in the vast majority of S. aureus isolates the anatomical site was
unspecified ‘pus’ and ‘unspecified fluid’, yielding 2 083 (86.6%) and
60 (2.5%) of isolates, respectively.
The male orthopaedic ward had the highest rate of MRSA (42
cases – 20.6% of MRSA SSTIs). Patients in the male medical ward
(odds ratio (OR) 4.5, 95% confidence interval (CI) 1.8 - 18.2, p=0.01)
were at increased odds of having a MRSA SSTI compared with SSTIs
in the neonatal unit. Fig. 1 displays the annual prevalence of MRSA.
The lowest proportion of MRSA SSTIs was in 2000 (15.9%) and the
highest proportion was in 2003 (27%; linear regression p=0.03 from
2000 to 2003). Although there was an increase in the proportion of
MRSA from 2000 to 2003, there were no further increases from 2003
to 2007 (p=0.48).
S. aureus isolates were routinely tested for susceptibility to
amoxicillin-clavulanate, cephradine, chloramphenicol, clindamycin,
erythromycin, gentamicin, methicillin, penicillin, tetracycline and
vancomycin. Susceptibility to TMP-SMX was not routinely tested;
results were available for only 18 isolates (Fig. 2). S. aureus was
most susceptible to vancomycin, clindamycin and chloramphenicol,
with susceptibility rates of 99.5%, 94.5% and 82.5%, respectively. No
chloramphenicol susceptibility data were available for 2000.
The antibiotic susceptibilities of MRSA and MSSA are compared in
Fig. 3. MRSA isolates were more likely to be resistant to clindamycin
(OR 26.1, 95% CI 15.1 - 46.2, p<0.001), erythromycin (OR 25.5, CI
15.8 - 41.3, p<0.001) and tetracycline (OR 31.0, 95% CI 17.8 - 55.9,
p<0.001), compared with MSSA isolates.

Discussion

The epidemiology and drug susceptibility of S. aureus SSTIs in
Botswana are described. There is a high proportion of S. aureus
SSTIs, particularly MRSA, at the tertiary hospital that serves the
population of southern Botswana. Significant factors that increase the
odds of MRSA infection among our cohort include age group 13 - 49
years, and hospitalisation in the intensive care unit, male orthopaedic
and male medical wards.
An increasing proportion of MRSA SSTIs in Botswana between
2000 and 2003 and high levels of MRSA resistance to commonly
used antibiotics are revealed. There is considerable variation
in MRSA resistance profiles between regions and countries. In
Australia, Singapore and Taiwan, MRSA is predominantly resistant
to ciprofloxacin, clindamycin, erythromycin, gentamicin, TMP/
SMX and tetracycline.13 In KwaZulu-Natal, South Africa, MRSA is
resistant to clindamycin, erythromycin and TMP/SMX. Similarly,
MRSA cases in this Botswana study displayed high resistance rates
to clindamycin, erythromycin and tetracycline. This susceptibility
pattern is of concern because patients with SSTIs in Botswana are
routinely treated with one of these medications or penicillin. The
empiric prescription of penicillin is probably targeting infection by
Streptococcus group A, but our findings suggest that S. aureus is an
under-recognised cause of SSTIs in Botswana.
Despite the Botswana Ministry of Health’s recommendation to
administer co-trimoxazole as the drug of choice for cutaneous
bacterial infections, which is supported by current US guidelines
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Table I. Demographic characteristics of patients with Staphylococcus aureus SSTI (N=857)
Patient characteristic

No. (%) with MSSA

No. (%) with MRSA

Unadjusted OR (95% CI)

p

26 (4.1)

8 (4.4)

Reference

-

Age group (N=818)
<1 mo.
1 - 11.9 mo.

12 (1.9)

2 (1.1)

0.5 (0.05 - 3.4)

0.5

1 - 4.9 yrs

31 (4.9)

9 (4.9)

0.9 (0.3 - 3.3)

0.9

5 - 12.9 yrs

99 (15.7)

17 (9.3)

0.6 (0.2 - 1.7)

0.2

13 - 49 yrs

327 (51.8)

114 (62.3)

1.1 (0.5 - 3)

0.8

>50 yrs

136 (21.6)

33 (18)

0.8 (0.3 - 2.2)

0.6

253 (42.2)

93 (44.9)

1.1 (0.8 - 1.6)

0.5

26 (4.5)

9 (4.4)

Reference

-

Gender (N=706)
Female
Ward type (N=780)
Neonatal nursery unit
Paediatric medical ward

23 (4)

2 (1)

0.3 (0.02 - 1.4)

0.08

Paediatric surgical ward

103 (17.9)

25 (12.3)

0.7 (0.3 - 1.9)

0.4

Male medical ward

7 (1.2)

11 (5.4)

4.5 (1.2 - 18.2)

0.01

Male surgical ward

60 (10.4)

32 (15.7)

1.5 (0.6 - 4.2)

0.3

Female medical ward

17 (3)

9 (4.4)

1.5 (0.4 - 5.3)

0.5

Female surgical ward

48 (8.3)

21 (10.3)

1.3 (0.5 - 3.6)

0.6

ICU

8 (1.4)

8 (3.9)

2.9 (0.7 - 11.8)

0.09

A&E

62 (10.8)

2 (1)

0.09 (0.009 - 0.5)

0.001

Male orthopaedic

132 (22.9)

42 (20.6)

0.9 (0.4 - 2.4)

0.8

Female orthopaedic

68 (11.8)

30 (14.7)

1.3 (0.5 - 3.5)

0.6

Private

9 (1.6)

6 (2.9)

1.9 (0.4 - 8.2)

0.3

Gynaecology

13 (2.3)

7 (3.4)

1.6 (0.4 - 6)

0.5

Fig. 1. Annual proportion
ortion of MRSA, 2000 - 2007. Linear regression for 2000 - 2003 shows
MSSA = methicillin-susceptible S. aureus; MRSA = methicillin-resistant S. aureus; OR = odds ratio; CI = confidence interval; ICU = intensive care unit; A&E = accident and emergency unit.
p=0.03; regression for 2000 - 2007, p=0.48.
Fig. 2. Antibiotic susceptibility profiles for S. aureus, 2000 - 2007. Antimicrobial susceptibility
data were not available at all times. This is why no row reaches 100%.
Susceptible

Resistant

Tetracycline (n=771)
Erythromycin (n=757)
Cephadrine (n=736)
Methicillin (n=663)
Gentamicin (n=784)
TMP-SMX (n=18)
Augmentin (n=588)
Chloramphen (n=779)
Ciprofloxacin (n=7)
Clindamycin (n=752)
Vancomycin (n=741)
0.0

10.0

20.0

30.0

40.0

50.0

60.0

70.0

80.0

90.0

100.0

Percent of S. aureus cases (%)

Fig. 1. Annual proportion of MRSA, 2000 - 2007. Linear regression for 2000 2003 shows p=0.03; regression for 2000 - 2007, p=0.48.

advocating TMP-SMX as the first-line therapy against communityacquired MRSA, S. aureus isolate susceptibilities to TMP-SMX
were not routinely tested. Additionally, we found that vancomycin,
the most effective antibiotic against MRSA, is not readily available
at health centres other than the main hospital. Hence, we propose
four improvements in managing SSTIs in Botswana: (i) revision
of Botswana’s national SSTI guidelines, including discontinuing
advocating penicillin as empiric treatment for SSTIs in a setting where
S. aureus accounts for more than a third of culture-positive SSTIs and
virtually all of these S. aureus isolates are resistant to this class of

Fig. 2. Antibiotic susceptibility profiles for S. aureus, 2000 - 2007. Antimicrobial susceptibility data were not available at all times. This is why no row
reaches 100%.

antibiotics (this has been achieved, as Botswana’s national antibiotic
guidelines, informed by information from this study, were revised
in July 2010); (ii) TMP-SMX susceptibility testing of all S. aureus
SSTI isolates; (iii) improved hospital infection control guidelines and
practices to prevent MRSA transmission in the hospital setting; and
(iv) vancomycin availability in district hospitals with strict guidelines
governing its use.
Limitations of this study include: (i) missing laboratory data from
our study period may have contributed to an underestimate of SSTI
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Fig. 3. Comparative susceptibility profiles of MRSA and MSSA.
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prevalence; (ii) the anatomical site was not known for most S. aureus
isolates, making it impossible to define the exact nature of each SSTI;
(iii) owing to the retrospective study design, standard laboratory
techniques may have shifted over the 8-year study period; and (iv)
our retrospective design makes our results susceptible to potential
biases of studies of similar design.
In summary, we found a high and increasing proportion of MRSA
SSTIs in Gaborone. Additionally, the high rate of MRSA resistance
to currently recommended empiric antibiotics for SSTIs dictates
the need for revising national guidelines and ongoing prospective
surveillance of SSTIs in this setting.
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ABSURD WORDS ABOUT BIRDS
I love to watch the busy EGRET
(both the she-gret and the he-gret)
But what a way to earn your keep. . .
Picking ticks off cows and sheep!
The egret has a graceful torso
And the HERON even more so.
See him, stone-still, in the creek,
S-shaped neck and dagger beak;
All-of-a-sudden with a swish!
Look – the heron has a fish!
Wheeling high up in the sky
The SEAGULL flies with raucous cry.
When underneath, you should be careful,
Or you’ll land up with a hairful.
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I wish the awkward HA-DI-DAH
Would learn to whistle, tweet or baa
A brownish bird, with fearsome beak
She calls her mate with rasping shriek
But someone loves the ha-di-dah
It is of course the ha-di-ma.
I’ve the greatest respect for the PLOVER
He is always so true to his lover
Her eggs he will shield
So exposed in the field
And he’ll never run off with anover.
Maurice Kibel Children’s poems

